{
    "title": "106_hr3305",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Dietary Supplement Fairness in \nLabeling and Advertising Act''.\n\nSEC. 2. LABELING OF DIETARY SUPPLEMENTS.\n\n    (a) Sense of Congress.--It is the sense of Congress that the \nproposed rule entitled ``Regulations on Statements Made for Dietary \nSupplements Concerning the Effect of the Product on the Structure or \nFunctions of the Body'', published in the Federal Register on April 29, \n1998, 63 Fed. Reg. 23624 (to be codified at part 101 of title 21, Code \nof Federal Regulations) would improperly restrict use of appropriate \nlabeling claims about the effect of a dietary supplement or dietary \ningredient on the structure or function of the human body.\n    (b) Effect of Regulations.--The proposed rule described in \nsubsection (a) shall not take effect.\n    (c) Dietary Supplement Labeling Exemptions.--Section 403B of the \nFederal Food, Drug, and Cosmetic Act (21 U.S.C. 343-2) is amended by \nadding at the end the following:\n    ``(d) Exemption From Regulation as Labeling.--A truthful and \naccurate summary of 1 or more of the findings of a study or article \nthat has appeared in a peer-reviewed medical, nutritional, or other \nscientific publication, or in a bona fide medical, nutritional, or \nother scientific textbook, shall not be subject to regulation as \nlabeling under this Act when used in connection with the sale of a \ndietary supplement to consumers, even if the summary is included in \nwritten, printed, or graphic matter that accompanies the dietary \nsupplement.''.\n\nSEC. 3. ADVERTISING OF DIETARY SUPPLEMENTS.\n\n    Section 5 of the Federal Trade Commission Act (15 U.S.C. 45) is \namended by adding at the end the following:\n    ``(o) Advertising of Dietary Supplements and Dietary Ingredients.--\n            ``(1) Definitions.--In this subsection:\n                    ``(A) Dietary supplement.--The term `dietary \n                supplement' has the meaning given that term by section \n                201(ff) of the Federal Food, Drug, and Cosmetic Act (21 \n                U.S.C. 321(ff)).\n                    ``(B) Dietary ingredient.--The term `dietary \n                ingredient' means an ingredient listed in section \n                201(ff)(1) (A) through (F) of the Federal Food, Drug, \n                and Cosmetic Act (21 U.S.C. 321(ff)(1) (A) through (F)) \n                that is included in, or that is intended to be included \n                in, a dietary supplement.\n            ``(2) Exemptions from regulation as advertising.--\n                    ``(A) Labeling.--Insofar as a publication is exempt \n                from regulation as labeling pursuant to section 403B of \n                the Federal Food, Drug, and Cosmetic Act (21 U.S.C. \n                343-2) the publication is also exempt from regulation \n                as advertising under the Federal Trade Commission Act.\n                    ``(B) Truthful and accurate summary.--A truthful \n                and accurate summary of 1 or more of the findings of a \n                cited study or article that has appeared in a peer-\n                reviewed medical, nutritional, or other scientific \n                publication, or in a bona fide medical, nutritional, or \n                other scientific textbook, when used in promotion for a \n                dietary supplement or dietary ingredient, shall not be \n                subject to regulation as advertising under the Federal \n                Trade Commission Act.\n            ``(3) Advertiser access to government scientific experts \n        before a regulatory action is initiated.--Before the Commission \n        files any complaint that initiates any administrative or \n        judicial proceeding alleging that an advertisement or \n        advertiser is not in compliance with the Federal Trade \n        Commission Act with respect to any advertising for a dietary \n        supplement or dietary ingredient, or for medical services or \n        health treatments, the Commission shall ensure that the \n        advertiser first--\n                    ``(A) has been provided a full and fair opportunity \n                to consult directly with all of the individuals whom \n                the Commission or Commission staff have relied upon or \n                intend to rely upon as nutritional, medical, or other \n                scientific experts with respect to the particular \n                allegations; and\n                    ``(B) has been provided a reasonable time \n                thereafter to communicate with the Commission staff and \n                the Commission with respect to the merits of the \n                experts' views.\n            ``(4) Reliance upon scientific data other than conclusive \n        human clinical studies.--It is not inherently or presumptively \n        deceptive, unfair, lacking in substantiation, or otherwise \n        improper for advertising about a dietary supplement or dietary \n        ingredient, or about medical services or health treatments, to \n        describe, mention, or rely upon in vitro laboratory studies, \n        animal feeding studies, human epidemiological studies, human \n        clinical studies that are of a preliminary nature and do not \n        provide a conclusive finding, meta-analyses, review articles, \n        or other bona fide medical, nutritional, or other scientific \n        texts if the advertising is truthful, not misleading, and \n        reveals the nature of the study or other information.\n            ``(5) Consent agreements.--In any case in which the \n        Commission enters into a consent agreement concerning \n        advertising about a dietary supplement or dietary ingredient, \n        or about medical services or health treatments, the agreement \n        shall apply only to the particular dietary supplements/\n        ingredients and particular health-related conditions, or to the \n        particular medical services or health treatments, or to other \n        particular matters, that are subjects of the complaint.''."
}